DataMEDS AI, Inc. - MEDS

SEC Filings Our MEDS Tweets

About Gravity Analytica

Recent News

11.05.2026 - DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
11.03.2026 - DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
11.02.2026 - DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
10.23.2026 - DataMEDS AI Establishes “Health Lives Here” Community Respiratory Program for Corexa Health Pharmacy Network
10.22.2026 - DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
10.20.2026 - DataMeds Regains Compliance With NASDAQ Listing Standards
10.16.2026 - DataMeds Applauds FDA’s Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health’s Peptides Roadmap
10.14.2026 - DataMEDS Si Licenses U.S. Rights To Reboot Health AI’s Direct-To-Consumer GLP-1 Weight Management Platform
10.13.2026 - DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
10.12.2026 - DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx® Assay In Gynecologic Cancers

Recent Filings